Skip to main content
Premium Trial:

Request an Annual Quote

Ubiquitome: Richard Creager

Richard Creager has been appointed to the board of directors of Aukland, New Zealand-based Ubiquitome. Creager most recently served as senior vice president of Beckman Coulter, where he was responsible for molecular diagnostics and led the introduction of the firm's Veris sample-to-answer molecular diagnostic system. He also served as Beckman's CSO, developing the technology and menu strategies for the company's immunoassay and molecular diagnostic businesses. He is currently CTO of nRichDX, a company developing liquid biopsy sample prep technology.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.